MUSC Center for Global Health
Request for Applications (RFA) for Faculty Pilot Project Grants
RFA Release Date: Monday, March 2, 2015
Full Proposal (5 page limit) Deadline: April 2, 2015, 12:00 p.m. EST
Earliest anticipated award notification: May 14, 2015
Late Applications will not be reviewed.
For full application details, click here: MUSC Center for Global Health RFA for Faculty Pilot Project Grants (.pdf)
The MUSC Center for Global Health (CGH) is pleased to announce that it will fund several pilot project grants for up to $20,000 for a 12-month period. We anticipate awarding between four to six grants through this funding process. Through this RFA, the CGH seeks to provide pilot funds to stimulate research in low and middle-income countries, with the larger goal of enabling investigators to leverage preliminary findings and data to become the basis of a competitive extramural research grant application. Projects that have the best potential for future growth and external funding will be prioritized for funding. Applications that include matching funds will be given preference.
This funding mechanism is designed to support research in low and middle-income countries (a listing of eligible countries can be found at the World Bank website). Applicants should describe plans for how the results generated will be applied to obtain future external funding.
Principal Investigator (PI) must have primary faculty appointment at MUSC. Applicants at all levels are eligible, and early-career investigators are especially encouraged to apply. Applicants must not have existing funding that can support the proposed research. Proposals may include collaborators from other institutions but the PI must be MUSC faculty.
SUBMISSION OF PROPOSAL
Proposal Due Date: April 2, 2015 at 12:00 p.m. EST
Access the South Carolina Translational Research (SCTR) Pilot Project website to submit your application at: http://academicdepartments.musc.edu/sctr/programs/pilot_projects The process includes uploading the following documents (PDF only): Biographical Sketch for all investigators, Project Description, Budget and Justification, Proposal. Letters of Support from foreign collaborators (encouraged, but optional) can be attached at the end of the Proposal.
1. Biographical Sketch. Please use PHS 398 Form Biographical Sketch Format Page in MS Word at http://grants.nih.gov/grants/funding/phs398/phs398.html Follow the 4-page limit, include a personal statement, and select up to 15 publications. If one of the Co-Investigators serves as a Co-PI, list the Co-PI as the first Co-Investigator on the online application and indicate by entering “(Co-PI)” after his/her last name. Personal statement of Co-Investigators must describe his/her role in the project. Convert the Word document to PDF to upload. NOTE: Please do not use PHS 398 PDF fillable forms, which are not compatible with the SCTR application system. Use the PHS 398 MS Word forms, and convert to PDF format to upload.
2. Project Description/Global Health Relevance. Provide a NIH-formatted, one-half page description (Arial font size 11, at least 0.5” margins). State the application's broad, long-term objectives, relevance to global health in low and middle-income countries, and specific aims. Summary should serve as a succinct and accurate description of the proposed work when separated from the application. Upload this PDF file to the Abstract & Relevance box at the bottom of the online application.
3. Budget and Justification. Please use PHS 398 Form Page 4: Detailed Budget for Initial
Budget Period in MS Word version at http://grants.nih.gov/grants/funding/phs398/phs398.html and use Continuation Format Page as needed for the budget justification. Each budget item listed in the Form Page 4 must be clearly justified. At the bottom of the online application, upload one single, combined PDF document (budget and justification) to the box labeled Budget and Justification.
NOTE: Do not use PHS 398 PDF fillable forms, as they are not compatible with the SCTR application system. Use the PHS 398 MS Word forms, and convert to PDF format to upload.
Faculty salary support is not allowed. All expenses must be directly related to proposed research. Facilities and administrative costs, also known as indirect costs, are not permitted.
4. Proposal. (5-page limit). (Arial font size 11, at least 0.5” margins PDF only). Follow NIH instructions for Research Strategy but with a five-page limit. The NIH Research Strategy instructions can be found at http://grants.nih.gov/grants/funding/phs398/phs398.pdf. The page limit excludes references, support letters and technical appendices. Include a description of the goal of the proposed study, preliminary data, hypothesis, specific aims, research design and methods, a description of the research team and research setting, and expected outcomes that would become the basis of a competitive extramural research grant application. Applicants should identify collaborating in-country investigators. Also, include the plans and timeline for receiving IRB clearance at both MUSC and in the country where the study will be conducted. Specify which institutions and national agencies in the host country will require ethical clearance. If you believe that the study is exempt from IRB approval at either MUSC or in the host country, provide a rationale for exemptions. At the bottom of the online application, upload one single, combined PDF document for all other Proposal documents (research strategy, letters of support, matching funds statement, etc.) to the box labeled Proposal.
5. It is not necessary to have approvals of all applicable institutional human, animal, and biosafety protocols (such as IRB, IACUC, IBC) to apply for this grant. However, approvals must be in place and documented before funding is released. Include no more than three documents such as reports and papers, survey instruments, and illustrations. Reference section should be limited to two pages. Technical appendices that contain material normally included within a proposal should not be attached and will not be considered. Convert the proposal, references, technical appendices and optional letters into a single PDF file to upload.
6. Letters of Support. A letter of support from a collaborating in-country investigator is strongly encouraged, but optional. Letters of support should be submitted as part of the single PDF file with the proposal, references and technical appendices.
Matching Funds. We encourage (but do not require) applicants to seek matching funds. Applications with matching funds will be given a higher priority. If matching funds are available to the investigator, submit a signed statement from the PI and the provider of matching funds, as part of the single PDF proposal document. Clearly indicate the source and amount of matching funds. The match must be in U.S. currency and can be from PI’s Department/Division, Center or Foundation grants but cannot be from existing grants.
Evaluation: Application will be evaluated by reviewers with appropriate expertise and ranked based on the review criteria as described below. Preference will be given to the most promising applications based on scientific merit, innovation, impact, and feasibility to become the basis of a competitive extramural research grant application. Selected applicants will be notified via email at the earliest anticipated date of May 14, 2015. Please see the application review criteria and process section below for more details.
- NOTE: Funds cannot be released until all applicable institutional human, animal, and biosafety protocols (such as IRB, IACUC, IBC), and any other required regulatory documents (such as INDs, IDE, and CITI Training) have been approved and documented.
- Principal investigators for funded projects will be required to submit an annual report and final progress report two years following the completion of their project to the Center for Global Health indicating: the number of subsequent grant applications, the funding outcome of these applications, and any publications or presentations that may have been based on the pilot grant.
- Awardees must agree to credit the MUSC Center for Global Health in any publication, publicity or applications that result from awards.
- It is the PI’s responsibility to inform the CGH office of any changes to the project, including departure from the PI’s institution. This will help to determine how both parties should proceed, such as transfer a PI’s responsibility to another team member or to close out the project.
- Awardees and business managers are encouraged to engage appropriate members of the Finance and Administration immediately upon receiving funds to ensure the best way to handle international financial transactions. International transactions can be complex and it is critical to plan ahead of time to ensure there are no delays in the research project. When possible, setting up a sub-award with the partnering institution can help alleviate transactional issues.
- International research typically requires IRB approval both in the U.S. and at the partnering institution. As international IRB approval can be time-consuming, starting the approval process as soon as possible will help keep the project on target.
For questions, contact Kathleen Ellis, CGH Director of Operations at email@example.com
South Carolina Clinical & Translational Research Institute (SCTR) has resources and consultation services (such as biostat, budget, regulatory, coordinator core and intellectual property consultations) that can help investigators interested in applying under this RFA. Please submit your request for a consultation (online link) or call the SCTR SUCCESS Center at 843-792-8300.
Application Review Criteria and Process
Reviewers for the applications will be identified from faculty with expertise in relevant scientific disciplines and current research areas. Reviewers are instructed to evaluate applications by addressing the core review criteria (listed below) as applicable based on the grant category.
Core Review Criteria for Overall Impact/Priority Score:
i. Significance including Scientific Merit of Proposed Project:
o Does the project address an important health problem or a critical barrier to progress in the field?
o If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved?
o How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
ii. Potential to Secure Future Extramural Funding:
o Does the project have high potential to secure future extramural funding?
o Are the PIs, collaborators, and other researchers well suited to the project? Do they have established roles, skills and experience to carry out the project?
o Is there clearly established new trans-disciplinary collaboration? i.e. collaboration between basic and clinicians, clinicians and community, and vice versa
o If Early Stage Investigators or New Investigators, do they have appropriate experience and training?
o If Early Stage Investigators, is there a defined mentorship plan with a senior/established investigator and timetable for becoming independent and a plan for achieving research independence and potential to lead to independent funding (with a plan to submit K or R applications)
o If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)?
o If the project is collaborative, do the investigators have complementary and integrated expertise; is their organizational structure appropriate for the project?
o Does investigator have a documented in-country collaborator appropriate to the project?
o Is the project new and innovative?
o Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions?
o Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense?
o Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?
o Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project?
o Are potential problems, alternative strategies, and benchmarks for success presented?
o If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed?
o If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as the inclusion of children, justified in terms of the scientific goals and research strategy proposed?
o Is there appropriate justification provided for the number of subjects (e.g. humans, animals) involved?
o Is the proposal feasible and will lead to success?
o Will the scientific environment in which the research will be done contribute to the probability of success?
o Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed?
o Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?
vii. Budget & Period Support:
o Is the budget and the requested period of support fully justified and reasonable in relation to the proposed research?